A Phase 1 Single-dose Open-label Pharmacokinetic (PK) Study of Abiraterone Acetate (AA) in Male Subjects With Mild or Moderate Hepatic Impairment

被引：1
|
作者：
Marbury, T. [1 ]
Stonerock, R. [1 ]
Acharya, M. [2 ]
Gonzalez, M. [2 ]
Jiao, J. [2 ]
Breeding, J. [3 ]
Haqq, C. [3 ]
Molina, A. [3 ]
Tran, N. [3 ]
机构：
[1] Orlando Clin Res Ctr, Orlando, FL USA
[2] Johnson & Johnson Pharmaceut, Res & Developlment, Raritan, NJ USA
[3] OrthoBiotech Oncol Res & Dev, Los Angeles, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72006-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S501 / S501
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of serelaxin in patients with hepatic impairment: a single-dose, open-label, parallel group study
    Kobalava, Zhanna
    Villevalde, Svetlana
    Kotovskaya, Yulia
    Hinrichsen, Holger
    Petersen-Sylla, Marc
    Zaehringer, Andreas
    Pang, Yinuo
    Rajman, Iris
    Canadi, Jasna
    Dahlke, Marion
    Lloyd, Peter
    Halabi, Atef
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (06) : 937 - 945
  • [32] Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
    Akifumi Kurata
    Takafumi Yoshida
    Megumi Inoue
    Tomoko Ishizuka
    Takafumi Nakatsu
    Takako Shimizu
    Manabu Kato
    Yasuhiro Nishikawa
    Hitoshi Ishizuka
    Advances in Therapy, 2020, 37 : 253 - 264
  • [33] Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
    Kurata, Akifumi
    Yoshida, Takafumi
    Inoue, Megumi
    Ishizuka, Tomoko
    Nakatsu, Takafumi
    Shimizu, Takako
    Kato, Manabu
    Nishikawa, Yasuhiro
    Ishizuka, Hitoshi
    ADVANCES IN THERAPY, 2020, 37 (01) : 253 - 264
  • [34] Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects
    Wong, YN
    King, SP
    Simcoe, D
    Gorman, S
    Laughton, W
    McCormick, GC
    Grebow, P
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (03): : 281 - 288
  • [35] Pharmacokinetics and bioequivalence of generic and branded abiraterone acetate tablet: a single-dose, open-label, and replicate designed study in healthy Chinese male volunteers
    Wang, Chunhua
    Hu, Chaoying
    Gao, Dan
    Zhao, Zirun
    Chen, Xiaoping
    Hu, Xiao
    Gong, Shili
    Li, Lin
    Zhang, Lan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 509 - 517
  • [36] Single-Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment: Results From an Open-Label, Phase 1 Trial
    Boinpally, Ramesh
    Jakate, Abhijeet
    Butler, Matthew
    Borbridge, Lisa
    Periclou, Antonia
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 726 - 733
  • [37] Single-Dose Pharmacokinetics and Safety of Ubrogepant in Adults With Hepatic Impairment: Results From an Open-Label, Phase 1 Trial
    Boinpally, Ramesh
    Lu, Kaifeng
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (07): : 857 - 864
  • [38] Pharmacokinetics and bioequivalence of generic and branded abiraterone acetate tablet: a single-dose, open-label, and replicate designed study in healthy Chinese male volunteers
    Chunhua Wang
    Chaoying Hu
    Dan Gao
    Zirun Zhao
    Xiaoping Chen
    Xiao Hu
    Shili Gong
    Lin Li
    Lan Zhang
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 509 - 517
  • [39] Effect of renal impairment on the pharmacokinetics of prucalopride: a single-dose open-label Phase I study
    Smith, William B.
    Mannaert, Erik
    Verhaeghe, Tom
    Kerstens, Rene
    Vandeplassche, Lieve
    Van de Velde, Vera
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 407 - 415
  • [40] Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects
    Qian, Hongjie
    Wu, Xue
    Chen, Qian
    Li, Tingting
    Wang, Wei
    Jia, Jingying
    Yu, Chen
    Li, Ke
    Sai, Yang
    Su, Weiguo
    Liu, Yanmei
    CLINICAL THERAPEUTICS, 2020, 42 (09) : 1778 - 1786
12345